FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Electronic Submission of eSTAR 510(k)s Needed: Consultant

Medical device regulatory consultant Adrienne Lenz says FDA needs to develop a way for medical device manufacturers to transmit electronic 510(k) subm...

Medical Devices

Arthrex Paying $16 Million to Resolve Kickback Case

The Justice Department says Arthrex is paying $16 million to resolve a whistleblowers allegations of kickbacks leading to False Claims Act payments.

Federal Register

Regulatory Review Period Determined for Dojolvi

Federal Register news: FDA determines for patent extension purposes the regulatory review period for Ultragenyxs Dojolvi (triheptanoin).

Federal Register

Info Collection: Antimicrobial Distribution Reporting

Federal Register notice: FDA seeks comments on an information collection extension entitled Antimicrobial Animal Drug Distribution Reports and Recordk...

Human Drugs

Biogen Probes Fatal Case of Aduhelm Patient

Biogen says it is investigating the death of a 75-year-old patient who had taken the companys controversial Alzheimers drug Aduhelm (aducanumab).

Human Drugs

Shorter Antibiotic Use Effective in 2 Uses: Studies

FDA says research it funded demonstrated that in two contexts shorter courses of antibiotic treatment were as effective as longer courses, reducing th...

CHPA Recommendations for Implementation of Genus Decision

The Consumer Healthcare Product Association recommends four steps FDA should take in implementing an appeals court decision on regulating drug/device ...

Human Drugs

CGMP Violations at Adamson Analytical Labs

FDA warns Adamson Analytical Laboratories about repeat CGMP violations in its work as a contract testing laboratory.

FDA General

ORA Embraces Remote Evaluations in Post Pandemic Arena

FDA Office of Regulatory Affairs assistant commissioner Elizabeth Miller tells an industry conference that her office has embraced the flexibility and...

Human Drugs

Study Questions Some Accelerated Approval Uses

Yale University researchers say giving sponsors extended periods to complete post-accelerated approval studies may not be justified.